Ivim Health and Semaglutide: Program Model and Compounded Pharmacy

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This entry from the PlexusDx Education Hub focuses on a single molecule and how one telehealth program handles it. For the wider library of GLP-1 and weight-management explainers, browse all Peptides & GLP-1 education.

What follows is independent editorial commentary. PlexusDx has no partnership, affiliate arrangement, or paid relationship with Ivim Health or its parent company.

Search for “Ivim Health semaglutide” and you are usually asking two questions at once: what semaglutide is, and how a telehealth service prescribes it. This review answers both, with fair-balance framing and no buying recommendation, current as of April 2026.

Semaglutide, the molecule behind the program

Semaglutide is a GLP-1 receptor agonist — it mimics a gut hormone that influences appetite signaling, gastric emptying, and glucose regulation. It sits in the same broad class as liraglutide and dulaglutide, and it is the active ingredient in several branded products used for metabolic and weight management. When a telehealth program talks about “semaglutide,” it may mean an FDA-approved brand product or a compounded preparation, and that distinction matters more than most marketing suggests.

Compounded semaglutide versus the branded pen

A 503A compounding pharmacy can prepare semaglutide against a valid prescription, which is a different supply route from a retail pharmacy dispensing a branded, FDA-approved pen. The active molecule is described the same way, but the products are not interchangeable regulatory entities: compounded preparations are not FDA-approved products, and availability, formulation, and presentation can differ. Any legitimate program should be transparent about which route it uses.

Why the dispensing route keeps coming up

The compounded-versus-brand question shows up in cost, in supply reliability, and in what a patient actually receives. It is the single most useful thing to confirm directly with a program before enrolling, because it shapes nearly everything downstream.

How a telehealth service like Ivim Health routes a semaglutide script

Ivim Health operates on a telehealth-plus-compounded-pharmacy model. In practice that means an intake questionnaire covering weight, history, and current medications; a licensed clinician's review and, if eligibility is met, a prescription; fulfillment through either a retail or a 503A compounding pharmacy; and follow-up to support titration and side-effect management. Provider type and pharmacy partner vary between programs. Confirm the current structure at Ivim Health's official website.

What the STEP trials established about semaglutide

The clinical backbone for semaglutide in weight management is the STEP program, published in The New England Journal of Medicine in 2021. Trial populations and endpoints differ from any individual's situation, and outcomes vary from person to person, but STEP is the evidence base that any serious discussion of semaglutide references. It describes the molecule's effect in studied populations, not a guaranteed personal result.

The genes that shape a semaglutide starting line

What no telehealth prescription reads is your own metabolic architecture. Variants in GLP1R — the very receptor semaglutide binds — along with FTO, MC4R, and TCF7L2 describe baseline appetite, satiety, and glucose-handling biology. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights spanning those variants. It does not predict whether semaglutide will work for you; it maps pathway-level context so you and your provider start from a fuller picture. PlexusDx offers this alongside its own Weight Management Protocols, including Semaglutide Injection and Semaglutide Oral.

See how the pieces fit: explore the Weight Management Protocols, or begin upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway before starting.

Frequently Asked Questions About Semaglutide and Ivim Health

Does Ivim Health prescribe compounded semaglutide or the brand?

Ivim Health uses a telehealth-plus-compounded-pharmacy model, which means a semaglutide prescription may be routed to a 503A compounding pharmacy or, for brand products, a retail pharmacy. Because the route affects cost and supply, confirm the current dispensing pathway directly on the brand's own website before enrolling.

Is compounded semaglutide the same as the branded version?

The active molecule is described the same way, but compounded preparations are not FDA-approved products and can differ in formulation, presentation, and availability. They are prepared by a 503A pharmacy against a prescription rather than manufactured as a branded pen. Treat them as related but not regulatory equivalents.

What did the STEP trials show about semaglutide?

The STEP program, published in The New England Journal of Medicine in 2021, is the primary clinical evidence for semaglutide in weight management. Trial populations and endpoints differ from any one person's situation, and individual outcomes vary, so STEP describes studied effects rather than a guaranteed personal result.

Can a genetic test tell me if semaglutide will work for me?

No. The Precision Peptide Genetic Test does not predict response to semaglutide or any specific compound. It analyzes pathway-level variants in GLP1R, FTO, MC4R, and TCF7L2 that describe baseline metabolic biology — upstream context for a provider conversation, not a forecast of medication results.

Not affiliated: PlexusDx is not affiliated with Ivim Health and has no commercial relationship with the companies referenced in this article.

Related reading on PlexusDx: Wegovy Coupon Without Insurance, Wegovy Cost Without Insurance, Cost Of Wegovy, Wegovy Shot.

Disclaimer: This article is educational. PlexusDx is not affiliated with Ivim Health and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.